Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
AstraZeneca
AstraZeneca
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Bristol-Myers Squibb
Medical College of Wisconsin
Incyte Corporation
Incyte Corporation
Janssen Research & Development, LLC
University of California, Irvine
Bristol-Myers Squibb
Sun Yat-sen University
Hoffmann-La Roche
Centre Leon Berard
Northwell Health
GlaxoSmithKline
J-Pharma Co., Ltd.
Shanghai Zhongshan Hospital
Incyte Corporation
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
UNICANCER
UNICANCER
Massachusetts General Hospital
Chang Gung Memorial Hospital
Sun Yat-sen University
GERCOR - Multidisciplinary Oncology Cooperative Group
Weill Medical College of Cornell University
Providence Health & Services
Nanjing Tianyinshan Hospital
McGill University Health Centre/Research Institute of the McGill University Health Centre
St. Olavs Hospital